Skip to main content

Table 1 Characteristics of participants by biomarker framework

From: Plasma β2-microglobulin and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact older adults: the CABLE study

Characteristics

Stage 0

Stage 1

Stage 2

SNAP

P

N

315

189

92

250

 < 0.001

Age (years)

61.89 ± 10.78

61.39 ± 10.753

68.48 ± 9.44

66.22 ± 9.75

 < 0.001

Female gender (N, %)

127 (40.3)

94 (49.7)

37 (48.0)

87 (37.6)

0.088

Education (years)

9.18 ± 4.11

9.61 ± 4.01

7.73 ± 4.60

8.7 ± 4.53

0.010

APOE ε4 carriers (N, %)

33 (10.4)

23 (12.1)

17 (18.4)

37 (14.8)

0.193

MMSE score

27.2 ± 3.69

27.46 ± 3.06

25.46 ± 4.19

26.77 ± 3.46

 < 0.001

MOCA

22.83 ± 5.21

22.81 ± 4.80

19.78 ± 5.83

21.71 ± 5.36

 < 0.001

CVF (yes/N)

148/167

94/95

51/41

135/115

0.294

Nephropathy (yes/N)

7/308

2/187

4/88

7/180

0.361

Hyperlipidemia (yes/N)

13/302

5/184

4/88

21/229

0.033

CHD (yes/N)

44/271

27/162

15/77

41/209

0.829

Stroke (yes/N)

17/298

8/181

3/89

17/232

0.508

Diabetes (yes/N)

44/271

35/154

12/80

51/199

0.125

Hypertension (yes/N)

114/201

77/112

41/51

111/139

0.177

Smoking status (yes/N)

85/230

41/148

20/72

74/176

0.216

Alcohol habit (yes/N)

97/218

44/145

21/71

70/180

0.217

Blood biomarkers

 BUN (nmol/l)

5.74 ± 1.91

5.69 ± 2.06

5.87 ± 1.81

5.83 ± 2.35

0.510

 Cr (μmol/l)

65.70 ± 25.51

66.71 ± 37.86

66.00 ± 22.95

68.17 ± 49.72

0.348

 BUN/Cr

0.09 ± 0.02

0.09 ± 0.42

0.09 ± 0.03

0.09 ± 0.23

0.972

 UA (μmol/l)

345.94 ± 93.97

337.98 ± 99.02

333.77 ± 82.65

347.74 ± 86.86

0.261

 β2-microglobulin (mg/l)

1.77 ± 0.77

2.11 ± 1.89

2.36 ± 1.26

2.13 ± 2.43

 < 0.001

CSF biomarkers

 Aβ1–42 (pg/ml)

341.24 ± 121.61

131.23 ± 44.51

135.54 ± 43.53

423.95 ± 176.26

 < 0.001

 Aβ1–40 (pg/ml)

6203.42 ± 3745.72

4882.97 ± 2774.09

7766.22 ± 4393.87

8790.70 ± 3670.17

 < 0.001

 T-tau (pg/ml)

156.91 ± 36.05

135.39 ± 37.95

311.79 ± 146.80

291.72 ± 101.41

 < 0.001

 P-tau (pg/ml)

37.33 ± 7.45

33.04 ± 8.46

59.47 ± 15.18

58.00 ± 15.04

 < 0.001

 Aβ1–42/Aβ1–40

0.057 (0.044–0.077)

0.030 (0.020–0.042)

0.019 (0.012–0.030)

0.048 (0.037–0.064)

 < 0.001

 T-tau/Aβ1–42

0.483 (0.371–0.631)

1.002 (0.749–1.483)

2.160 (1.521–3.356)

0.680 (0.488–0.973)

 < 0.001

 P-tau/Aβ1–42

0.116 (0.089–0.152)

0.249 (0.193–0.359)

0.441 (0.324–0.583)

0.143 (0.106–0.190)

 < 0.001

  1. Categorical variables are reported as numbers and percentages; continuous variables are reported as means ± SDs
  2. Abbreviations: MMSE Mini-Mental State Examination, MOCA Montreal Cognitive Assessment, APOE apolipoprotein E, CHD coronary heart disease, CVF cardiovascular factors (including stroke, coronary heart disease, hypertension, diabetes), BUN blood urea nitrogen, Cr creatinine, UA uric acid, 1–42 amyloid-β1–42, 1–40 amyloid-β1–40, T-tau total tau, P-tau phosphorylated tau